Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Betterlife Pharma Inc (OP: BETRF ) 0.0753 UNCHANGED Streaming Delayed Price Updated: 11:22 AM EDT, Apr 29, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 0.0753 Bid (Size) N/A (0) Ask (Size) N/A (0) Prev. Close 0.0753 Today's Range 0.0753 - 0.0753 52wk Range 0.0309 - 0.0941 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More April 17, 2024 Via Benzinga BetterLife To Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference April 11, 2024 From BetterLife Pharma Inc. Via GlobeNewswire Performance YTD +29.60% +29.60% 1 Month +2.03% +2.03% 3 Month +31.41% +31.41% 6 Month +72.71% +72.71% 1 Year +19.90% +19.90% More News Read More Psychedelics Headlines: Substitution Survey, Frank Herbert's Magic Mushrooms, Celestial Plans And News Review March 16, 2024 Via Benzinga BetterLife Announces Closing of $1.168 Million Convertible Debentures to Further Advance IND-enabling Studies of its Non-hallucinogenic LSD-based Drug Candidate BETR-001 April 03, 2024 From BetterLife Pharma Inc. Via GlobeNewswire BetterLife Announces Closing of Convertible Debentures For Further Development of BETR-001 January 02, 2024 From BetterLife Pharma Inc. Via GlobeNewswire BetterLife’s 2-Bromo-LSD for Treatment of Depression Highlighted by Carleton University March 04, 2024 From BetterLife Pharma Inc. Via GlobeNewswire BetterLife Announces Closing of a Private Placement December 18, 2023 From BetterLife Pharma Inc. Via GlobeNewswire BetterLife Announces Extension of Warrants November 30, 2023 From BetterLife Pharma Inc. Via GlobeNewswire BetterLife Pharma to Host Investors Update Call on September 18, 2023 September 14, 2023 From BetterLife Pharma Inc. Via GlobeNewswire US Patent and Trademark Office Publishes BetterLife’s Comprehensive Patent for BETR-001 and Other LSD Derivatives November 15, 2023 From BetterLife Pharma Inc. Via GlobeNewswire BetterLife Obtains Favourable Animal Safety Data for Repeated Oral Dosing of BETR-001 September 12, 2023 From BetterLife Pharma Inc. Via GlobeNewswire BetterLife Highlights BETR-001 Article in Technology Networks Drug Discovery and Announces Closing of a Private Placement September 05, 2023 From BetterLife Pharma Inc. Via GlobeNewswire Psyched: A $100M Donation Pledge, Frank Biden Gets Candid, New Search Trends & More July 04, 2023 Via Benzinga BetterLife Highlights American College of Physicians’ Updated Guidelines for Treating Depression and Announces Closing of Private Placement July 13, 2023 From BetterLife Pharma Inc. Via GlobeNewswire BetterLife Fast Tracks Its US Patent For Non-Hallucinogenic Compound And Other LSD Derivatives June 28, 2023 Via Benzinga BetterLife Fast Tracks Its US Patent for BETR-001 and Other LSD Derivatives June 27, 2023 From BetterLife Pharma Inc. Via GlobeNewswire BetterLife To Present BETR-001 Preclinical Data at the 32nd Annual Meeting of the International Behavioural Neuroscience Society (IBNS) in Niagara Falls, Ontario, Canada June 22, 2023 From BetterLife Pharma Inc. Via GlobeNewswire Psyched: Dubai Psychedelics Event, Key Receptor Discovered, Drew Barrymore, Oprah's Guest, Swiss MDMA & More June 13, 2023 Via Benzinga BetterLife's Non-Hallucinogenic LSD's Clinical Studies, Braxia's Psychedelic Treatments Continue June 09, 2023 Via Benzinga BetterLife Continues Progress on BETR-001 IND-Enabling Studies June 08, 2023 From BetterLife Pharma Inc. Via GlobeNewswire BetterLife To Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference April 20, 2023 From BetterLife Pharma Inc. Via GlobeNewswire BetterLife To Present BETR-001 Preclinical Data at the 2023 Annual Meeting of the Society of Biological Psychiatry (SOBP) in San Diego, California April 25, 2023 From BetterLife Pharma Inc. Via GlobeNewswire Promise of BetterLife's Non-hallucinogenic LSD (BETR-001) For Treating Mood Disorders Highlighted in Medical Xpress Article March 22, 2023 From BetterLife Pharma Inc. Via GlobeNewswire BetterLife's Non-hallucinogenic LSD (BETR-001) For Treating Mood Disorders Highlighted in Drug Discovery & Development Article March 29, 2023 From BetterLife Pharma Inc. Via GlobeNewswire Psyched: Next-Gen Compounds For Depression, Congress, Rescheduling, Benzinga Psychedelics Conference & More March 13, 2023 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
